Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact

Launched by UNIVERSITY OF WASHINGTON · Jul 5, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving suicide prevention for adolescents aged 10 to 18 years old in pediatric primary care settings. It aims to adapt an existing suicide prevention program called SAFETY-Acute, which helps identify and support young people who may be at risk for suicide. The goal is to make it easier for doctors and healthcare providers to recognize and address suicidal thoughts and behaviors among teens, thereby reducing the risk of suicide, a leading cause of death in this age group.

To participate in this trial, young people must be between 10 and 18 years old, speak fluent English, and have a low to moderate risk for suicide (meaning they do not have a current plan or intention to harm themselves). Parents or caregivers of these adolescents who are 18 years and older can also take part in the study. Participants can expect to receive support and resources aimed at enhancing their safety and well-being. It’s important to note that this study is not yet recruiting participants, so there is still time to learn more about it.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • adolescent between the ages of 10 and 18 years old
• • speaks fluent English
• • current or past low to moderate suicide risk (denies current plan or intent to kill self)
• Exclusion Criteria:
• • high suicide risk (endorses current plan or intent or ASQ score =5, or prior attempt within last 3 months)
• • does not speak fluent English
• Note: Caregivers of 10-18 yr olds will also be included so age limits for participating samples include:
• • 1. Adolescents: ages 10-18 years old
• • 2. Parents/Caregivers: ages 18 years and older